Xenon Pharmaceuticals (XENE) Tops Q4 EPS by 1c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q4 EPS of ($0.84), $0.01 better than the analyst estimate of ($0.85).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• UBS says bull market has further to run
• Rithm Capital Corp. (RITM) PT Lowered to $14 at UBS on Higher for Longer Rates
• PennyMac Mortgage Investment Trust (PMT) PT Lowered to $10 by UBS on Lower MSR Earnings